Futura’s lead project is Eroxon®, a unique topical treatment for erectile dysfunction which has been approved without the need for a prescription and is available in 27 countries, including in the USA and Europe.
Countries were Eroxon® has launched
United States
Central and South America
Mexico
Costa Rica
Panama
Europe
UK
Ireland
Norway
Sweden
Finland
Denmark
Portugal
Spain
France
Belgium
Netherlands
Italy
Hungary
Romania
Estonia
Lativa
Lithiania
Middle East
Jordan
Kuwait
Saudi Arabia
Iraq
Qatar
United Arab Emirates